Full List of Active Sites
Welcome,         Profile    Billing    Logout  
 3 Trials 
9 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rafii, Michael S
ALADDIN, NCT06911944: Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation

Not yet recruiting
4
60
NA
Donanemab, Kisunla, Placebo
Michael Rafii, MD, PhD, National Institute on Aging (NIA), Eli Lilly and Company, Alzheimer's Clinical Trials Consortium, Alzheimer's Therapeutic Research Institute
Down Syndrome (DS), Down Syndrome (Trisomy 21), Alzheimer Disease, Amyloid Beta Protein
12/27
12/27
ABATE, NCT05462106: A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome ( Study)

Recruiting
1/2
140
Europe, US
Placebo, ACI-24.060 at Dose A, ACI-24.060 at Dose B, ACI-24.060 at Dose C, ACI-24.060 at Dose D, ACI-24.060 at Dose X, ACI-24.060 at Dose Y
AC Immune SA, Worldwide Clinical Trials
Alzheimer's Disease, Prodromal Alzheimer's Disease, Amyloid Plaque, Beta-Amyloid, Alzheimer's Disease in Down Syndrome
06/26
06/26
ALZ-NET, NCT06170268: Alzheimer's National Registry for Treatment and Diagnostics

Recruiting
N/A
20000
US
Routine Care Documentation
Alzheimer's Disease and Related Disorders Association, Inc, American College of Radiology, The Critical Path Institute, Brown University, American Society of Neuroradiology
Alzheimer Disease
12/32
12/32
TRC-DS, NCT04165109: Trial-Ready Cohort-Down Syndrome

Recruiting
N/A
450
Europe, US
Flutafuranol, [18F]NAV4694, NAV4694, Pittsburgh Compound (PIB), [11C]-PIB, PIB, MK6240, [18F]MK-6240
University of Southern California, National Institute on Aging (NIA), Alzheimer's Clinical Trials Consortium, Alzheimer's Therapeutic Research Institute
Down Syndrome, Alzheimer Disease, Dementia
12/25
12/25
Rabinovici, Gil
ALZ-NET, NCT06170268: Alzheimer's National Registry for Treatment and Diagnostics

Recruiting
N/A
20000
US
Routine Care Documentation
Alzheimer's Disease and Related Disorders Association, Inc, American College of Radiology, The Critical Path Institute, Brown University, American Society of Neuroradiology
Alzheimer Disease
12/32
12/32
LEADS, NCT03507257: Longitudinal Early-onset Alzheimer's Disease Study Protocol

Recruiting
N/A
850
Europe, US, RoW
Flortaucipir, 18F-AV-1451 (also known as [F-18]T807 or LY3191748), Florbetaben, AV-45, Neuraceq, Fluorodeoxyglucose, FDG
Indiana University, Alzheimer's Therapeutic Research Institute, National Institute on Aging (NIA), Alzheimer's Association
Early Onset Alzheimer Disease, Alzheimer Disease, Mild Cognitive Impairment
05/25
05/25
NCT04426539: New IDEAS: Imaging Dementia-Evidence for Amyloid Scanning Study

Recruiting
N/A
7000
US
American College of Radiology, Alzheimer's Association
Alzheimer's Disease, Dementia, Mild Cognitive Impairment
12/24
12/24
Carillo, Maria C
ALZ-NET, NCT06170268: Alzheimer's National Registry for Treatment and Diagnostics

Recruiting
N/A
20000
US
Routine Care Documentation
Alzheimer's Disease and Related Disorders Association, Inc, American College of Radiology, The Critical Path Institute, Brown University, American Society of Neuroradiology
Alzheimer Disease
12/32
12/32
https://wwwalz-netorg/Find-a-Site, Go to Site Finder
ALZ-NET, NCT06170268: Alzheimer's National Registry for Treatment and Diagnostics

Recruiting
N/A
20000
US
Routine Care Documentation
Alzheimer's Disease and Related Disorders Association, Inc, American College of Radiology, The Critical Path Institute, Brown University, American Society of Neuroradiology
Alzheimer Disease
12/32
12/32
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Rafii, Michael S
ALADDIN, NCT06911944: Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation

Not yet recruiting
4
60
NA
Donanemab, Kisunla, Placebo
Michael Rafii, MD, PhD, National Institute on Aging (NIA), Eli Lilly and Company, Alzheimer's Clinical Trials Consortium, Alzheimer's Therapeutic Research Institute
Down Syndrome (DS), Down Syndrome (Trisomy 21), Alzheimer Disease, Amyloid Beta Protein
12/27
12/27
ABATE, NCT05462106: A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome ( Study)

Recruiting
1/2
140
Europe, US
Placebo, ACI-24.060 at Dose A, ACI-24.060 at Dose B, ACI-24.060 at Dose C, ACI-24.060 at Dose D, ACI-24.060 at Dose X, ACI-24.060 at Dose Y
AC Immune SA, Worldwide Clinical Trials
Alzheimer's Disease, Prodromal Alzheimer's Disease, Amyloid Plaque, Beta-Amyloid, Alzheimer's Disease in Down Syndrome
06/26
06/26
ALZ-NET, NCT06170268: Alzheimer's National Registry for Treatment and Diagnostics

Recruiting
N/A
20000
US
Routine Care Documentation
Alzheimer's Disease and Related Disorders Association, Inc, American College of Radiology, The Critical Path Institute, Brown University, American Society of Neuroradiology
Alzheimer Disease
12/32
12/32
TRC-DS, NCT04165109: Trial-Ready Cohort-Down Syndrome

Recruiting
N/A
450
Europe, US
Flutafuranol, [18F]NAV4694, NAV4694, Pittsburgh Compound (PIB), [11C]-PIB, PIB, MK6240, [18F]MK-6240
University of Southern California, National Institute on Aging (NIA), Alzheimer's Clinical Trials Consortium, Alzheimer's Therapeutic Research Institute
Down Syndrome, Alzheimer Disease, Dementia
12/25
12/25
Rabinovici, Gil
ALZ-NET, NCT06170268: Alzheimer's National Registry for Treatment and Diagnostics

Recruiting
N/A
20000
US
Routine Care Documentation
Alzheimer's Disease and Related Disorders Association, Inc, American College of Radiology, The Critical Path Institute, Brown University, American Society of Neuroradiology
Alzheimer Disease
12/32
12/32
LEADS, NCT03507257: Longitudinal Early-onset Alzheimer's Disease Study Protocol

Recruiting
N/A
850
Europe, US, RoW
Flortaucipir, 18F-AV-1451 (also known as [F-18]T807 or LY3191748), Florbetaben, AV-45, Neuraceq, Fluorodeoxyglucose, FDG
Indiana University, Alzheimer's Therapeutic Research Institute, National Institute on Aging (NIA), Alzheimer's Association
Early Onset Alzheimer Disease, Alzheimer Disease, Mild Cognitive Impairment
05/25
05/25
NCT04426539: New IDEAS: Imaging Dementia-Evidence for Amyloid Scanning Study

Recruiting
N/A
7000
US
American College of Radiology, Alzheimer's Association
Alzheimer's Disease, Dementia, Mild Cognitive Impairment
12/24
12/24
Carillo, Maria C
ALZ-NET, NCT06170268: Alzheimer's National Registry for Treatment and Diagnostics

Recruiting
N/A
20000
US
Routine Care Documentation
Alzheimer's Disease and Related Disorders Association, Inc, American College of Radiology, The Critical Path Institute, Brown University, American Society of Neuroradiology
Alzheimer Disease
12/32
12/32
https://wwwalz-netorg/Find-a-Site, Go to Site Finder
ALZ-NET, NCT06170268: Alzheimer's National Registry for Treatment and Diagnostics

Recruiting
N/A
20000
US
Routine Care Documentation
Alzheimer's Disease and Related Disorders Association, Inc, American College of Radiology, The Critical Path Institute, Brown University, American Society of Neuroradiology
Alzheimer Disease
12/32
12/32

Download Options